5:06 PM
 | 
Jun 27, 2018
 |  BC Extra  |  Company News

Management tracks: Arrakis, Astellas

Arrakis Therapeutics Inc. (Waltham, Mass.) founder and CSO Russ Petter is transitioning to Jennifer Petter. The news was announced in a blog post by Chairman and CEO Michael Gilman. "The support for this transition at Arrakis, on the part of the investors, management, and the research team, has been outstanding," Petter told BioCentury. The company discovers and develops RNA-targeted small...

Read the full 283 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >